CDKN2A and neoplasm: Mutations in the 22 SMGs from the primary tumour set also frequently occurred in cell lines, with TP53, NOTCH1/2 and CDKN2A the most recurrently altered with similar mutational profiles in primary tumour samples and cell lines (Fig. 8c, Supplementary Data 29 and Supplementary Fig. 13).